| Name | Title | Contact Details |
|---|
Recombinant Data Corp. is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AlphaVax is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kiwi-Tek is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RWJBarnabas Health is the most comprehensive health care delivery system in New Jersey, treating over 3 million patients a year. The system includes eleven acute care hospitals – Clara Maass Medical Center in Belleville, Community Medical Center in Toms River, Jersey City Medical Center in Jersey City, Monmouth Medical Center in Long Branch, Monmouth Medical Center Southern Campus in Lakewood, Newark Beth Israel Medical Center in Newark, RWJUH in New Brunswick and Somerville, RWJUH- Hamilton, RWJUH- Rahway and Saint Barnabas Medical Center in Livingston; three acute care children`s hospitals and a leading pediatric rehabilitation hospital (Children`s Specialized Hospital), a freestanding 100-bed behavioral health center, ambulatory care centers, geriatric centers, the state`s largest behavioral health network, comprehensive home care and hospice programs, fitness and wellness centers, retail pharmacy services, a medical group, multi-site imaging centers and four accountable care organizations. RWJBarnabas Health is New Jersey`s second largest private employer – with more than 32,000 employees, 9,000 physicians and 1,000 residents and interns – and routinely captures national awards for its outstanding quality and safety.
AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.